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Abstract: Cancer is the second leading cause of death in the US and in Mississippi. Breast 
cancer  (BC)  is  the  most  common  cancer  among  women,  and  the  underlying 
pathophysiology remains unknown, especially among African American (AA) women. The 
study purpose was to examine the joint effect of menopause status (MS) and hormone 
replacement therapy (HRT) on the association with cancers, particularly BC using data 
from the Jackson Heart Study. The analytic sample consisted of 3202 women between 35 
and 84 years of which 73.7% and 22.6% were postmenopausal and on HRT, respectively. 
There were a total of 190 prevalent cancer cases (5.9%) in the sample with 22.6% breast 
cancer cases.  Menopause  (p < 0.0001),  but  not  HRT (p = 0.6402), was independently 
associated with cancer. Similar results were obtained for BC. BC, cancer, hypertension, 
type  2  diabetes,  prevalent  cardiovascular  disease,  physical  activity  and  certain  dietary 
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practices were all significantly associated with the joint effect of menopause and HRT in 
the unadjusted analyses. The family history of cancer was the only covariate that was 
significantly  associated  with  cancer  in  the  age-adjusted  models.  In  examining  the 
association of cancer and the joint effect of menopause and HRT, AA women who were 
menopausal and were not on HRT had a 1.97 (95% CI: 1.15, 3.38) times odds of having 
cancer compared to pre-menopausal women after adjusting for age; which was attenuated 
after further adjusting for family history of cancer. Given that the cancer and BC cases 
were small and key significant associations were attenuated after adjusting for the above 
mentioned covariates, these findings warrant further investigation in studies with larger 
sample sizes of cancer (and BC) cases. 
 
Keywords: cancer; breast cancer; hormone replacement therapy; pre and post menopause; 
African Americans; Jackson Heart Study; joint effect, association  
 
1. Introduction  
Medical research has reported that cancer follows cardiovascular disease as the second leading 
cause of death, claiming the lives of over half a million adults annually [1]. Breast cancer is considered 
to be the most common form of cancer and the second leading cause of death among women in the 
United States. It is estimated that there could be more than 14,330 new cases of cancer in Mississippi 
and 1,529,560 cases in the U.S. In 2009, it was estimated that there would be 192,370 new diagnoses 
of invasive breast cancer and approximately 40,170 women are expected to die from breast cancer [2]. 
African American women are disproportionately represented in poor survival outcomes, and cancer 
mortality [3-6].  
The Jackson Heart Study was initiated as a response to American health disparities in the US with a 
view to gaining a better understanding of key factors in the development of cardiovascular disease in 
African Americans [7]. Few studies have examined disease risks in a setting where data on risk factors 
for  CVD  have  been  collected  along  with  participant  information  regarding  the  prevalence  and 
incidence of different types of cancers. The Jackson Heart Study, therefore, has provided a unique 
opportunity for researchers to examine cancer status in relation to traditional and emerging CVD risk 
factors. In this paper, we examined the association of the joint effect of menopause and hormone 
replacement therapy and cancer in African American women in the Jackson Heart Study.  
2. Study Design and Methods  
The  Jackson  Heart  Study  (JHS)  is  a  prospective  cohort  study  of  cardiovascular  disease  in  
non-institutionalized African American adults aged 21–95 residing in the Jackson, MS metropolitan 
area  (MSA).  The  JHS  is  the  largest  single-site  prospective  epidemiologic  investigation  of 
cardiovascular disease in African Americans. The state of Mississippi has the highest percentage of 
African American residents (36.9%) of any state in the U.S. Participants were recruited from urban and 
rural areas of three counties in the Jackson MSA, which includes Hinds, Madison, and Rankin counties. Int. J. Environ. Res. Public Health 2011, 8                 
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Overall,  17%  of  JHS  participants  were  recruited  through  random  sampling  of  the  Jackson  MSA 
commercial database (Accudata), 22% as family members, 31% from the Jackson, MS site of the 
National Heart, Lung, and Blood Institute’s Atherosclerosis Risk in Communities study, and 30% as 
volunteers.  The  final  JHS  cohort  included  5,301  participants,  equivalent  to  6.6%  of  all  African 
Americans  residing  in  the  Jackson  MSA.  Data  utilized  in  the  analysis  were  obtained  from  JHS 
examination  1  (2000–2004)  and  the  JHS  examination  1  annual  follow-up  interview  which  was 
completed within three months of the anniversary date of the original visit. Study design has been 
detailed elsewhere [8-14].  
The analytic sample size for this study is 3202 and it was derived using the exclusion criteria: a) 
exclusion  of  all  male  participants  and  b)  exclusion  of  female  participants  who  were  21–34  and  
85–95 years old to minimize the potential of have a highly correlated data set, since these women were 
strictly recruited for the family study. The sample size for the analysis involving the joint effects of 
menopause and HRT was 3142 due to further exclusion of women who were pre-menopausal on HRT. 
The  JHS  variables  utilized  in  this  study  were  grouped  into  the  following:  outcome  measures, 
reproductive measures, demographic and socioeconomic measures, clinical risk factors and behavioral 
risk factors, which included dietary practices. 
Outcome  Measures.  The  primary  and  secondary  outcome  variables  were  prevalent  cancer  and 
prevalent breast cancer, respectively. Both prevalent cancer and breast cancer cases were defined by 
the participants responses to the following questions: (1) “Has your doctor or health care professional 
ever  said  you  have  cancer?”  This  question  was  taken  from  the  Personal  and  Family  History 
Questionnaire; (2) “Has a doctor ever said you had cancer?”; or (3)“Have you had another cancer?” 
Questions two and three were taken from the annual follow-up questionnaire. The date of diagnosis 
was prior to the participant’s JHS Exam 1 visit date.  
Reproductive Measures. Women who responded “yes”, at the baseline examination, to having had 
menstrual periods or bleeding during the past two years were classified as pre menopausal. Women 
who responded “no” to the same question were classified as post menopausal. Women were classified 
as currently taking HRT, if they responded “yes” to either of the following questions: are you currently 
taking: (a) first identified hormone, (b) second identified hormone or (c) third identified hormone in 
the reproductive history questionnaire?, and provided proof of hormone use based on medications that 
were brought to clinic visit. Medications were transcribed
 and coded as HRT by a pharmacist using
 the 
Medispan dictionary and classified according to the Therapeutic Classification System. History of 
contraceptive use was ascertained based on the history of taking birth control pills included in the JHS 
Reproductive History Questionnaire.  
Demographic and Socioeconomic Measures. Demographic information, including age and gender 
were  obtained  at  the  examination.  Socioeconomic  status  was  measured  by  annual  family  income. 
Income was self reported in the following categories: less than $5,000; $5,000–7,999; $8,000–11,999; 
$12,000–15,999;  $16,000–19,999;  $20,000–24,999;  $25,000–34,999;  $35,000–49,999;  
$50,000–74,999; $75,000–99,999; $100,000 or more. Income was classified as low, lower-middle, 
upper-middle, and high based upon family size, number of children <18 years of age and the U.S. 
Census designated poverty level for the year in which the income information was obtained. Low 
income was defined as below the poverty level for the corresponding family size/number of children 
combination. High income was defined as more than four times the poverty level threshold for each Int. J. Environ. Res. Public Health 2011, 8                 
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family  size  by  child  grouping.  The  two  middle  income  categories  were  divided  at  2.5  times  the  
poverty level.  
Clinical Risk Factors. The clinical risk factors for cardiovascular disease examined in this paper 
included hypertension, diabetes, and obesity. Standardized questionnaires were used to obtain medical 
history information and medication usage within the past two weeks of exam 1 for diabetes and high 
blood  pressure,  and  participants  were  asked  to  bring  their  medications  to  the  examination.  To 
determine hypertension status, two resting blood pressure readings were taken one minute apart at the 
exam using a Hawksley random-zero
 sphygmomanometer (Hawksley and Sons Ltd.) and averaged. 
Hypertension was defined according to JNC VII criteria as systolic blood pressure ≥140 mmHg or 
diastolic blood pressure ≥90 mmHg at exam, or use of blood pressure lowering medication (self-report 
and actual) within 2 weeks prior to the examination, or self-reported history of hypertension.  
Fasting blood samples were also taken at the exam and blood glucose was measured at a central 
laboratory. Type II diabetes was defined according to American Diabetes Association 2004 criteria as 
fasting glucose ≥126 mg/dL, or confirmed medication inventory or self-reported use of anti-diabetic 
medications, or self-reported diabetes diagnosis. Body mass index (BMI) was derived to determine 
overweight/obesity status. BMI was calculated in kg/m
2 using measurements of weight and height at 
the exam while participants wore light clothing and no shoes. Obesity was defined according to the 
World Health Organization standard of BMI ≥ 30. 
Behavioral Risk Factors. Current smoking status was self-reported by participants at the exam as 
having smoked 400 cigarettes or more in his/her lifetime and having smoked within 3 months of the 
JHS baseline interview. Heavy alcohol drinkers were defined as persons who consumed greater than 
24 grams of alcohol per day. Physical activity was assessed using the Jackson Heart Study Physical 
Activity Cohort instrument derived from modification of the Baecke physical activity survey [15]. 
Total physical activity was computed as a summary score of the intensity, frequency, and duration of 
activities  associated  with:  active  living,  including  transportation  and  leisure  time  activities;  home, 
family, yard, and gardening activities; occupational activities, and sport participation. The summary 
score was validated against results from 24-hour accelerometer and pedometer monitoring. Dietary 
measures used in this study were determined from participant responses to the JHS food frequency 
short-form  questionnaire  developed  in  conjunction  with  the  Human  Nutrition  Research  Center  on 
Aging at Tufts University and the Delta Nutrition Intervention Research Initiative (sponsored by the 
US Department of Agriculture). The validation and calibration of the JHS food frequency short-form 
questionnaire are detailed by [16]. 
Data Analytic Plan. Descriptive statistics were used to describe the characteristics of the study 
sample. Two-sample t-tests were performed to compare cancer cases and breast cancers cases with 
their  respective  controls  for  all  the  demographic,  SES,  lifestyle  and  clinical  factors  which  were 
continuous  in  nature.  For  the  categorical  factors  chi-square  tests  were  performed  to  examine  the 
association of the factors with prevalent cancer and prevalent breast cancer. These chi-square tests 
were  performed  for  the  purpose  of  identifying  potential  cofounders  to  be  adjusted  for  in  further 
analyses. Also, chi-square tests were used to examine the association of prevalent cancer and breast 
cancer with the joint effect of menopause status and hormone replacement therapy (HRT). The general 
linear  modeling  (GLM)  approach  was  used  to  assess  differences  among  the  three  groups  defined  
by the joint effect of menopause  and HRT. The test of association between prevalent cancer and  Int. J. Environ. Res. Public Health 2011, 8                 
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breast  cancer  and  the  joint  effect  of  menopause  and  HRT  was  conducted  by  means  of  multiple  
(multivariable-adjusted) logistic regression; which computed the odds ratios (OR) and 95% confidence 
intervals (CI). Age and covariates that were significantly associated with both outcome measures were 
included in each of the multiple logistic regression models. A significance level of 0.05 was used in all  
inferential analyses. 
3. Results  
Table 1 below summarizes the demographic, medical and reproductive histories of the women in 
the Jackson Heart Study included in this study. The mean (standard deviation [SD]) age of the analytic 
sample was 56 (11) years with a mean body mass index of 32.8 (SD = 7.4) kg/m
2. Generally, the study 
participants  were  well  educated  with  approximately  61%  reporting  greater  than  a  high  school 
education; and 55.7% having a family income that placed them in the upper-middle to affluent income 
class. Their health profile concerning medical and reproductive history suggested that about 60% had a 
family history of cancer, 73.7% were post menopausal and 22.6% reported use of hormones. The mean 
(SD) number of pregnancies and live-born children were 3.5 (2.5) and 3.2 (2.2), respectively. There 
were a total of 190 prevalent cancer cases (5.9%) in the sample with 22.6% of them being breast 
cancer (See Figure 1). Colon and uterine cancer constituted 5.8% and 5.3% of the total prevalent 
cancer cases. The most common hormone used was estrogen with a negligible percentage on progestin. 
See Figure 2 for details of distribution.  
Table  1.  Baseline  characteristics  of  african  american  women  (35–84  years)  in  JHS  
(n = 3,202). 
Characteristics  N (%) 
Age( years)  56 ±  11 
BMI, (Kg/m
2)  32.8 ±  7.4 
Obesity (%)  60.3 
Education Level (%)   
  Less than HS  18.4 
  High School/GED  20.6 
  Greater than HS but less than BA/BS  27.7 
  Bachelor Degree or Higher  33.3 
Family Income (%)   
  Low  17.3 
  Lower- Middle  27.0 
  Upper Middle  29.9 
  Affluent  25.8 
Family History of Cancer (%)  1,576 (59.8) 
Total number of pregnancies  3.5 ±  2.5 
Total number of live born children  3.2 ±  2.2 
Menopausal Post (%)  2,338 (73.7) 
HRT Use (%)  710 (22.6) 
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Figure 1. Distribution of types of cancer among women (35–84 years) in JHS (n = 190). 
 
Others: Abdomen, Chest, Kidney, Insite-2, Leg, Nasal, Skin, Throat, Thyroid, Vulva, 
Right arm, Moles, and NonHogkins. 
Figure  2.  Distribution  of  types  of  hormone  replacement  therapy  among  women  
(35–84 years) in JHS (n = 1,216).  
 
 
The comparative analysis of prevalent cancer cases and controls suggest that the cases were on 
average 6 years older (Table 3). The two groups were different in the following dietary practices: total 
fat intake (p = 0.0267), total vitamin E intake (p = 0.0349), Lycopene (p < 0.0001), and % calories 
from  alcohol  (p  =  0.029).  Physical  activity  as  measured  by  Home  and  Yard  activities  differed 
significantly between the two groups (p = 0.0433). There was a significant difference in the mean age 
of  onset  for  use  of  birth  control  pills  between  the  two  groups  (p  =  0.0050).  The  prevalence  of 
hypertension (p = 0.030) and Type 2 diabetes mellitus (p = 0.0196) was significantly higher in those 
with prevalent cancer than in those without cancer.  
Similar to Table 2, Table 3 provides comparisons of breast cancer cases and controls. Similar to 
prevalent cancer, the prevalent breast cancer cases were 7 years older than the controls (p < 0.0012). 
There was no significant difference between the two groups on the dietary practice measures. The post 
menopause status was more frequent in the breast cancer cases than in controls (94.6% vs. 73.4%;  
p = 0.0037).  
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Table 2. Comparative analysis of socio-demographic, behavioral and clinical risk factors 
by prevalent cancer status. 
Characteristics  Non-Cancer 
(n = 3,012) 
Cancer 
(n = 190) 
P-Value 
Age (years)  56 ±  11  62 ±  11  <0.0001 
BMI, (Kg/m
2)  32.8 ±  7.4  31.9 ±  6.9  0.0914 
Obesity  60.5  56.1  0.2331 
Education Level      0.4203 
  Less than HS  18.40  20.53   
  High School/GED  20.59  19.47   
  Greater than HS but less than BA/BS  27.68  31.58   
  Bachelor Degree or Higher  33.33  28.42   
Family Income      0.7465 
  Low  17.28  19.23   
  Lower- Middle  26.98  29.49   
  Upper Middle  29.92  26.92   
  Affluent  25.82  24.36   
Current Smoking, Yes  10.33  8.47  0.4126 
Heavy Alcohol Use (%)  5.71  6.52  0.8055 
Fruit Intake (grams/day)  1.5 ±  1.1  1.5 ±  0.8  0.8412 
Vegetable Intake (grams/day)  1.4 ±  0.6  1.3 ±  0.5  0.0635 
% Calories due to Fat  34.9 ±  7.2  34.1 ±  7.0  0.1100 
Amt. of Fat Intake (grams)  76.4 ±  47.5  69.6 ±  39.2  0.0267 
Total Dietary Fiber (grams)  14.7 ±  7.0  14.1 ±  5.5  0.1489 
Beta-Carotene (Mcg)  3,288 ±  1,545  3,190 ±  1,512  0.4043 
Total Vitamin E (Mg)  66.1 ±  107.9  85.7 ±  121.9  0.0349 
Vitamin C (Mg)  188.9 ±  190.2  210.7 ±  207.4  0.1344 
Lycopene (Mcg)  4,209 ±  4,989  3,253 ±  2,921  < 0.0001 
%Calories from Alcohol  0.5 ±  2.0  0.3 ±  1.2  0.0291 
Post Menopausal (%)  72.7  89.0  < 0.0001 
HRT Use, Yes (%)  22.8  21.3  0.6402 
Types of HRT      0.6402 
  Estrogen  74.5  67.1  0.2987 
  Progestin  1.1  0.0  0.7143 
  Estrogen & Progestin  12.6  8.2  0.1767 
Family History of Cancer  59.0  71.7  0.0019 
Physical Activity Total   8.1 ±  2.6  7.3 ±  2.6  < 0.0001 
Active Living  2.1 ±  0.8  2.0 ±  0.8  0.2479 
Home and Garden  2.3 ±  0.6  2.2 ±  0.6  0.0443 
Sport Index  2.1 ±  1.2  2.0 ±  1.2  0.1418 
Work Index  2.6 ±  0.7  2.6 ±  0.6  0.7368 
Type Two Diabetes   20.12  27.37  0.0196 
Hypertension  66.14  73.91  0.0300 
Prevalent CVD  9.25  12.77  0.2331 
Age start taking birth control pills  22 ±  5  23 ±  5  0.0050 
Age stop taking birth control pills  30 ±  7  30 ±  6  0.9026 
Years you have used birth control  8 ±  6  7 ±  5  0.0710 Int. J. Environ. Res. Public Health 2011, 8                 
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Table 3. Comparative analysis of socio-demographic, behavioral and clinical risk factors 
by prevalent breast cancer. 
Characteristics  Non-Breast Cancer 
(n = 3,165) 
Breast Cancer 
(n = 37) 
P-Value 
Age, years  56 ±  12  63 ±  10  0.0012 
BMI, (Kg/m
2)  32.8 ±  7.4  32.4 ±  6.8  0.7548 
Obesity  60.3  62.2  0.8207 
Education Level      0.9104 
  Less than HS  18.65  16.22   
  High School/GED  20.46  21.62   
  Greater than HS but less than BA/BS  27.85  32.43   
  Bachelor Degree or Higher  33.05  29.73   
Family Income      0.8961 
  Low  17.44  20.0   
  Lower- Middle  27.30  23.33   
  Upper Middle  29.70  26.67   
  Affluent  25.57  30.0   
Current Smoking, Yes  10.25  2.70   
Heavy Alcohol Use (%)  5.76  0.0  0.0707 
Fruit Intake (grams/day)  1.5 ±  1.1  1.6 ±  0.7  0.3092 
Vegetable Intake (grams/day)  1.4 ±  0.6  1.3 ±  0.4  0.0776 
% Calories due to Fat  34.9 ±  7.2  34.6 ±  7.8  0.8336 
Amt. of Fat Intake (grams)  75.8 ±  47.0  80.8 ±  47.4  0.5305 
Total Dietary Fiber (grams)  14.7 ±  6.9  14.8 ±  5.2  0.8968 
Beta-Carotene (Mcg)  3286 ±  1544  3056 ±  1239  0.3799 
Total Vitamin E (Mg)  67.0 ±  108.6  74.5 ±  1193.2  0.6813 
Vitamin C (Mg)  189.3 ±  190.6  227.1 ±  224.9  0.2437 
Lycopene (Mcg)  4144 ±  4900  3663 ±  2250  0.2250 
%Calories from Alcohol  0.5 ±  1.9  0.3 ±  1.1  0.4515 
Post Menopausal (%)  73.4  94.6  0.0037 
HRT Use, Yes (%)  22.7  13.5  0.1853 
Types of HRT       
  Estrogen  74.2  61.5  0.1637 
  Progestin  1.0  0.0  0.3710 
  Estrogen & Progestin  12.3  0.0  0.2732 
Family History of Cancer  59.7  65.5  0.5269 
Physical Activity Total   8.1 ±  2.6  7.7 ±  2.0  0.4029 
Active Living  2.1 ±  0.8  2.0 ±  0.8  0.6252 
Home and Garden  2.3 ±  0.6  2.3 ±  0.6  0.8008 
Sport Index  2.1 ±  1.2  2.0 ±  1.2  0.6959 
Work Index  2.6 ±  0.7  2.5 ±  0.7  0.5325 
Type Two Diabetes   20.54  27.78  0.2858 
Hypertension  66.56  80.56  0.0764 
Prevalent CVD  9.44  5.56  0.4167 
Age start taking birth control pills  22 ±  5  24 ±  5  0.0953 
Age stop taking birth control pills  30 ±  7  31 ±  5  0.3383 
Years you have used birth control  8 ±  6  7 ±  5  0.3157 Int. J. Environ. Res. Public Health 2011, 8                 
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To examine the joint effect of HRT and menopause, the three subgroups (pre-menopausal women 
without  HRT,  post-menopausal  women  not  on  HRT  and  post-menopausal  women  on  HRT)  were 
compared  with  respect  to  the  factors  and  outcome  measures  considered  in  this  study  (Table  4). 
Assessing differences across the three groups the following were significant: age (p < 0.0001), BMI  
(p  =  0.0063),  vegetable  intake  (p  <  0.0001),  %  calories  due  to  fat  (p  <  0.0001),  total  fat  intake  
(p < 0.0001), total dietary fiber (p = 0.0006), Beta-Carotene (p = 0.0209), total vitamin E (p < 0.0001), 
vitamin C (p = 0.0053), Lycopene (p < 0.0001), % calories due to alcohol (p = 0.0008), age of onset of 
birth control pill (p < 0.0001), duration of birth control pill use (p < 0.0001) and all five measures of 
physical activity (total score (p < 0.0001), Home & Yard (p < 0.0001), active living(p < 0.0001), work 
index  (p  =  0.0103)  and  sport  index  (pp  <  0.0001).  The  joint  effect  of  menopause  and  HRT  was 
significantly associated with education level (p < 0.0001), family income (p < 0.0001), ever taking 
birth control pills (p < 0.0001), type 2 diabetes mellitus (p < 0.0001), hypertension (p < 0.0001), 
prevalent CVD (p < 0.0001), prevalent breast cancer (p = 0.0223) and prevalent cancer (p = 0.0008).  
Table 4. Relation of risk factor correlates and the joint effect of menopause and hrt in  
jhs (3,142)*. 
Characteristics 
Pre- 
Menopause 
(n = 835) 
Post- 
Menopause 
w/out HRT 
(n = 1,673) 
Post- 
Menopause  
w/HRT 
(n = 634) 
P-Value 
Age, years  45 ±  8  61 ±  10  58 ±  9  <0.0001 
BMI, (kg/m
2)  33.3 ±  8.3  32.9 ±  7.2  32.0 ±  6.7  0.0063 
Obesity, Yes  61.44  61.12  56.99  0.1463 
Education Level        <0.0001 
  Less than High School  6.73  25.52  14.80   
  High School/GED  15.63  23.67  19.21   
  Greater than HS but less than BA/BS   36.90  23.55  28.35   
  Bachelor Degree or Higher  40.75  27.26  37.64   
Family Income        <0.0001 
  Low  16.45  20.75  10.70   
  Lower- Middle  21.70  31.20  23.89   
  Upper Middle  35.60  25.86  31.37   
  Affluent  26.24  22.19  34.05   
Current Smoking, Yes  10.71  10.17  8.85  0.4860 
Heavy Alcohol Use  6.3  6.0  3.4  0.5325 
Fruit Intake  1.4 ±  1.1  1.5 ±  1.1  1.5 ±  1.1  0.1369 
Vegetable Intake  1.5 ±  0.7  1.4 ±  0.6  1.4 ±  0.6  <0.0001 
% Calories due to Fat  36.4 ±  7.2  34.2 ±  7.0  34.4 ±  7.2  <0.0001 
Amt. of Fat Intake  89.6 ±  53.1  70.5 ±  43.4  70.3 ±  38.3  <0.0001 
Total Dietary Fiber  15.4 ±  7.1  14.4 ±  6.9  14.3 ±  6.1  0.0006 
Beta-Carotene  3,183 ±  1,629  3,280 ±  1,477  3,408 ±  1,462  0.0209 
Total Vitamin E  52.7 ±  95.9  66.9 ±  108.8  85.1 ±  120.4  <0.0001 
Vitamin C  177.9 ±  175.0  187.5 ±  190.7  210.2 ±  208.1  0.0053 
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Table 4. Cont. 
Characteristics 
Pre- 
Menopause 
(n = 835) 
Post- 
Menopause 
w/out HRT 
(n = 1,673) 
Post-
Menopause  
w/HRT 
(n = 634) 
P-Value 
Lycopene  4,969 ±  5,998  3,827 ±  4105  3,754 ±  4,139  <0.0001 
%Calories from Alcohol  0.7 ±  2.4  0.4 ±  1.8  0.4 ±  1.4  0.0008 
Ever taken Birth Control, Yes  82.5  49.5  62.9  <0.0001 
Age of Onset Use of Birth Control   20 ±  4  23 ±  5  23 ±  5  <0.0001 
Duration of Use of Birth Control  9 ±  7  7 ±  6  8 ±  6  <0.0001 
Family History of Cancer  51.72  63.50  60.34  <0.0001 
Physical Activity Total   9.0 ±  2.3  7.6 ±  2.6  8.2 ±  2.5  <0.0001 
Active Living  2.2 ±  0.8  2.0 ±  0.8  2.1 ±  0.8  <0.0001 
Home and Garden  2.4 ±  0.6  2.2 ±  0.6  2.2 ±  0.5  <0.0001 
Sport Index  2.2 ±  1.2  2.0 ±  1.2  2.2 ±  1.2  <0.0001 
Work Index  2.6 ±  0.7  2.7 ±  0.6  2.6 ±  0.6  0.0103 
Breast Cancer  0.84  2.09  0.94  0.0223 
Cancer (General)  3.40  11.05  7.33  <0.0000 
Type Two Diabetes   11.0  25.3  20.2  <0.0001 
Hypertension  43.4  73.8  78.3  <0.0001 
Prevalent CVD  4.1  12.7  8.1  <0.0001 
* Women who were pre-menopausal and on HRT (n = 60) were excluded from the analysis. 
 
Prevalent cancer was associated with age (OR: 1.04; 95% CI: 1.03, 1.06), and family history of 
cancer (OR: 1.55; 95% CI: 1.07, 2.23) in age-adjusted models. However, for breast cancer it was only 
associated with age (OR: 1.05; CI: 1.02, 1.08). None of the demographic and socioeconomic measures, 
and  clinical  and  behavior  risk  factors  were  independently  associated  with  the  outcome  measures 
(Cancer and breast cancer). Data is not presented in this paper. In unadjusted models the odds of 
prevalent cancer was significantly higher in post-menopausal women who were not on HRT (OR: 3.33; 
CI: 2.09, 5.32) and those who were on HRT (OR: 2.31; CI: 1.34, 4.00) compared to women who were 
pre-menopausal (Table 5). However, in the age-adjusted models, the odds of prevalent cancer was 
higher in post-menopausal women who were not on HRT (OR: 1.97; CI: 1.15, 3.38) but not in women 
who were on HRT (OR: 1.53; CI: 0.85, 2.75) when compared to pre-menopausal women. The earlier 
association between prevalent cancer and the joint effect of menopause and HRT was diminished when 
age and family history of cancer were adjusted for as covariates. However, in the case of prevalent 
breast  cancer,  post-menopausal  women  who  were  not  on  HRT  showed  significantly  higher  odds 
compared  to  pre-menopausal  women  in  both  the  unadjusted  (OR:  7.59;  CI:  1.81,  31.82)  and  
age-adjusted models (OR: 4.85; CI: 1.03, 22.85).  
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Table  5.  Association  of  prevalent  cancer  and  breast  cancer  with  the  joint  effect  of 
menopause and hrt. 
Outcome  Models  Pre-Menopause 
Post-Menopause 
w/out HRT 
Post-Menopause 
w/ HRT 
Prevalent Cancer  I  1.00  3.33 (2.09,5.32)  2.31 (1.34,4.00) 
  II  1.00  1.97 (1.15,3.38)  1.53 (0.85,2.75) 
  III  1.00  1.76 (0.98,3.17)  1.54 (0.81,2.91) 
Prevalent Breast Cancer         
  I  1.00  7.59 (1.81,31.82)  3.29 (0.64,17.03) 
  II  1.00  4.85 (1.03,22.85)  2.32 (0.42,12.74) 
  III  1.00  3.56 (0.73,17.43)  1.79 (0.30,10.60) 
Model I: unadjusted; Model II: Age-adjusted; Model III: adjusted for Age and Family History of Cancer. 
4. Conclusions  
In  this  study,  several  factors  in  the  following  domains  of  measurement,  Demographic  and 
Socioeconomic, Clinical and Behavioral Risk Factors, were identified as factors that were associated 
with prevalent cancer and breast cancer. Also, several of these factors were significantly associated 
with the joint effect of menopause status and HRT. Though collection of cancer-related data was 
limited in the JHS cohort, the estimated prevalence of cancer in African American women represented 
by the JHS was 5.9%, slightly more than half of the prevalence of cardiovascular disease (9.5%) in the 
same sample population. This finding seems consistent with the ratio of CVD and cancer mortality in 
the State of Mississippi, the two most common causes of mortality in the state. Of the types of cancers 
in this sample, the most prevalent was breast cancer, which represented 22.6% of all cancers cases. 
These findings were consistent with the literature that refers to breast cancer as the most common form 
of cancer and the second leading cause of death among women in the United States [1]. 
The unadjusted comparison of dietary practices, total fat intake, total vitamin E intake, Lycopene 
and % calories from alcohol significantly differ between cancer and non cancer cases. However, these 
significant  associations  were  attenuated  in  the  age  adjusted  logistic  models.  This  study  does  not 
support earlier findings in the literature that certain lifestyles, such as dietary practices, tobacco use, 
alcohol consumption, weight gain, and physical activity, as well as high blood pressure, considered 
traditional  CVD  risk  factors,  may  be  linked  to  the  development  of  both  CVD  and  cancer  (and 
particularly breast cancer). However, given the small number of cancer cases, it is important to note 
that the study findings underscore that there is little known association between dietary practices and 
cancer in African American women [17-19]. Thus, this warrants further investigation. The mean % 
calories due to fat in the study sample was high for all subgroups (cancer vs. non-cancer), (breast 
cancer vs. non-breast cancer) and (pre-menopause, post-menopause without HRT and post-menopause 
with HRT) based on the cut-point of greater than 30% of total energy consumed set forth by the 
National Institute of Health’s National Heart, Lung, and Blood Institute [20].  
Physical activity measured by home and yard activities was significantly associated with cancer in 
the unadjusted models. However these associations were attenuated in the age adjusted models. The 
mean age of the onset of use of birth control pills, and two classical CVD risk factors, hypertension 
and Type 2 diabetes mellitus, were also significantly related to cancer. However, these significant Int. J. Environ. Res. Public Health 2011, 8                 
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findings  were  not  evident  for  prevalent  breast  cancer.  A  plausible  explanation  could  be  the  low 
prevalence of breast cancer (1.1%) in the study sample.  
Since menopause, but not HRT, was independently associated with cancer, and the joint effect of 
menopause and HRT suggested that post-menopausal women who were not on HRT had higher odds 
ratios of cancer (and breast cancer) compared to pre-menopausal and post-menopausal women who 
were on HRT, further investigation of these findings is warranted. The pursuit of the recommended 
further studies in this area of scientific investigation is very important for the following reasons. The 
number of cancer and breast cancer cases in this study was relatively small and the findings could be 
validated or challenged with studies of larger numbers of cancer or breast cancer cases. Secondly, [21] 
reported that  the  assessment  of  the  risks  and benefits  of HRT  relative  to  cancer,  CVD  and  other 
chronic diseases in African Americans and other non-white women is very limited given their lack of 
or minimal participation in clinical studies on HRT. 
Perspective. Though data for classifying cancer and especially breast cancer was limited in the 
Jackson  Heart  Study  compared  to  extensive  data  on  CVD  outcomes  and  risk  factors,  this  study 
provides  insight  into  the  potential  of  ascertaining  additional  data  specific  to  cancer  etiology, 
progression and survival, given the extensive data on biological and psychosocial determinants of 
cancer morbidity and mortality as outcome measures. The reproductive history coupled with repeated 
data collection on medication use, provides a foundation for future studies of cancer that utilizes the 
Jackson Heart Study data.  
Given that the Jackson Heart Study is a longitudinal study, it provides scientific resources for future 
recommended investigations that may examine the joint effects of menopause and HRT on the risk of 
developing cancer (breast cancer) in African American women.  
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